OCGN RSI Chart
Last 7 days
51.9%
Last 30 days
72.6%
Last 90 days
264.4%
Trailing 12 Months
16.9%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jan 03, 2024 | musunuri shankar | sold (taxes) | -117,673 | 0.653 | -180,204 | chief executive officer |
Jan 03, 2024 | upadhyay arun | sold (taxes) | -27,186 | 0.653 | -41,633 | see remarks |
Sep 16, 2023 | upadhyay arun | sold (taxes) | -345 | 0.41 | -842 | see remarks |
Jun 16, 2023 | upadhyay arun | sold (taxes) | -467 | 0.51 | -917 | chief scientific officer |
Jun 14, 2023 | zhang junge | bought | 99,998 | 0.4993 | 200,278 | - |
Feb 16, 2023 | musunuri shankar | sold | -108,000 | 1.08 | -100,000 | chief executive officer |
Feb 16, 2023 | musunuri shankar | acquired | 33,000 | 0.33 | 100,000 | chief executive officer |
Jan 17, 2023 | musunuri shankar | acquired | 51,000 | 0.51 | 100,000 | chief executive officer |
Jan 17, 2023 | musunuri shankar | sold | -128,000 | 1.28 | -100,000 | chief executive officer |
Jan 03, 2023 | musunuri shankar | sold (taxes) | -47,346 | 1.25 | -37,877 | chief executive officer |
Which funds bought or sold OCGN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC Financial Services Group, Inc. | sold off | -100 | -400 | - | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 0.96 | 2,152,730 | 6,922,950 | -% |
Mar 04, 2024 | VIMA LLC | new | - | 210 | 210 | -% |
Feb 26, 2024 | Virtu Financial LLC | sold off | -100 | -14,000 | - | -% |
Feb 16, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | added | 98.83 | 70,000 | 108,000 | -% |
Feb 16, 2024 | HARBOUR INVESTMENTS, INC. | unchanged | - | 18.00 | 58.00 | -% |
Feb 16, 2024 | GSA CAPITAL PARTNERS LLP | new | - | 33,000 | 33,000 | -% |
Feb 15, 2024 | JANE STREET GROUP, LLC | reduced | -93.19 | -69,925 | 7,583 | -% |
Feb 15, 2024 | GTS SECURITIES LLC | new | - | 6,281 | 6,281 | -% |
Feb 15, 2024 | LUMINUS MANAGEMENT LLC | reduced | -40.26 | -153,777 | 935,285 | 0.26% |
Unveiling Ocugen Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Ocugen Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 42.3B | 6.8B | -8.96 | 6.17 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.4B | 1.8B | -44.17 | 10.64 | ||||
BMRN | 16.7B | 2.4B | 99.73 | 6.91 | ||||
INCY | 12.8B | 3.7B | 21.46 | 3.47 | ||||
MID-CAP | ||||||||
APLS | 7.1B | 396.6M | -13.34 | 17.78 | ||||
BBIO | 5.4B | - | -8.31 | 60.35 | ||||
AXSM | 3.8B | 270.6M | -15.68 | 13.86 | ||||
ARWR | 3.6B | 240.7M | -11.98 | 14.77 | ||||
ACAD | 3.0B | 726.4M | -48.93 | 4.13 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.85 | 4.82 | ||||
NVAX | 678.8M | 983.7M | -1.25 | 0.69 | ||||
CRBP | 373.2M | 881.7K | -8.37 | 466.16 | ||||
INO | 304.5M | 4.9M | -2.25 | 62.57 | ||||
IBIO | 11.8M | 2.1M | -0.43 | 2.14 |
Ocugen Inc News
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | -16.1% | 75.00 | 89.00 | 96.00 | 109 | 116 | 130 | 142 | 106 | 116 | 124 | 54.00 | 27.00 | 21.00 | 24.00 | 12.00 | 17.00 | 24.00 | 4.00 | 15.00 | 2.00 | 11.00 |
Current Assets | -23.0% | 57.00 | 73.00 | 84.00 | 98.00 | 107 | 123 | 138 | 103 | 113 | 122 | 51.00 | 26.00 | 20.00 | 23.00 | 11.00 | 16.00 | 23.00 | 3.00 | 8.00 | 2.00 | 6.00 |
Cash Equivalents | -24.2% | 54.00 | 71.00 | 68.00 | 78.00 | 102 | 115 | 130 | 95.00 | 107 | 116 | 45.00 | 24.00 | 19.00 | 15.00 | 3.00 | 8.00 | 15.00 | 1.00 | 0.00 | 2.00 | 2.00 |
Net PPE | 23.5% | 14.00 | 12.00 | 8.00 | 6.00 | 5.00 | 3.00 | 2.00 | 1.00 | - | - | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.00 |
Liabilities | -12.9% | 16.00 | 19.00 | 20.00 | 25.00 | 21.00 | 16.00 | 11.00 | 10.00 | 9.00 | 8.00 | 7.00 | 6.00 | 6.00 | 9.00 | 5.00 | 6.00 | 37.00 | 10.00 | 20.00 | 15.00 | 21.00 |
Current Liabilities | -17.3% | 11.00 | 13.00 | 16.00 | 18.00 | 15.00 | 10.00 | 8.00 | 7.00 | 6.00 | 5.00 | 4.00 | 4.00 | 4.00 | 7.00 | 3.00 | 5.00 | 35.00 | 9.00 | 2.00 | 14.00 | 9.00 |
Short Term Borrowings | - | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | 1.00 | 4.00 | - | - | - | 2.00 | 1.00 | 7.00 | - |
Long Term Debt | 1.6% | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | - | 1.00 | - |
LT Debt, Current | 0.8% | 1.00 | 1.00 | 1.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | 1.6% | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | - | 1.00 | - |
Shareholder's Equity | -16.9% | 58.00 | 70.00 | 76.00 | 84.00 | 95.00 | 114 | 131 | 96.00 | 107 | 116 | 46.00 | 22.00 | 14.00 | 15.00 | 7.00 | 11.00 | - | - | - | - | - |
Retained Earnings | -5.6% | -266 | -252 | -229 | -213 | -191 | -169 | -149 | -131 | -117 | -106 | -80.38 | -73.30 | -69.50 | -59.04 | -55.40 | -51.48 | -63.86 | -41.09 | -226 | 31.00 | -216 |
Additional Paid-In Capital | 0.7% | 322 | 320 | 303 | 295 | 284 | 281 | 279 | 226 | 222 | 221 | 125 | 93.00 | 82.00 | 72.00 | 62.00 | 62.00 | 51.00 | 35.00 | 220 | 18.00 | 206 |
Shares Outstanding | 0.0% | 256 | 256 | 226 | 222 | 213 | 216 | 206 | 199 | 194 | 196 | 186 | 184 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | - | 483 | - | - | - | 1,600 | - | - | - | 29.00 | - | - | - | 18.00 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | 27.1% | -13,706 | -18,806 | -18,240 | -16,914 | -14,302 | -13,797 | -15,066 | -12,804 | -8,053 | -21,801 | -5,283 | -4,283 | -2,653 | -3,087 | -4,686 | -8,743 | -2,118 | -3,363 | -2,667 | -2,786 | -3,081 |
Share Based Compensation | -17.4% | 2,174 | 2,632 | 2,689 | 2,668 | 2,495 | 2,079 | 3,299 | 2,683 | 1,347 | 2,095 | 833 | 163 | 126 | 149 | 222 | 164 | 193 | 112 | 415 | 329 | 226 |
Cashflow From Investing | -158.8% | -3,365 | 5,723 | 3,441 | -15,295 | -83.00 | -1,366 | -223 | -192 | -350 | -1,013 | -261 | -251 | -22.00 | 19.00 | -53.00 | -20.87 | -2,204 | -121 | -10.58 | - | -793* |
Cashflow From Financing | -100.2% | -35.00 | 15,404 | 5,496 | 8,175 | 962 | 236 | 50,102 | 605 | 110 | 93,664 | 26,297 | 9,467 | 6,813 | 14,843 | 488 | 907 | 18,945 | 3,855 | 1,359 | 1,931 | -706 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Operating expenses | ||||
Research and development | $ 6,342 | $ 15,622 | $ 30,069 | $ 32,544 |
General and administrative | 9,082 | 7,497 | 26,839 | 28,174 |
Total operating expenses | 15,424 | 23,119 | 56,908 | 60,718 |
Loss from operations | (15,424) | (23,119) | (56,908) | (60,718) |
Other income (expense), net | 1,262 | 1,197 | 3,323 | 1,306 |
Net loss | (14,162) | (21,922) | (53,585) | (59,412) |
Other comprehensive income (loss) | ||||
Foreign currency translation adjustment | 5 | 20 | 2 | 30 |
Unrealized gain (loss) on marketable securities | 0 | 0 | (1) | 0 |
Comprehensive loss | $ (14,157) | $ (21,902) | $ (53,584) | $ (59,382) |
Shares used in calculating net loss per common share - basic (in shares) | 256,492,558 | 216,591,011 | 240,222,667 | 212,755,746 |
Shares used in calculating net loss per common share - diluted (in shares) | 256,492,558 | 216,591,011 | 240,222,667 | 212,755,746 |
Net loss per share of common stock - basic (in USD per share) | $ (0.06) | $ (0.10) | $ (0.22) | $ (0.28) |
Net loss per share of common stock - diluted (in USD per share) | $ (0.06) | $ (0.10) | $ (0.22) | $ (0.28) |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 53,477 | $ 77,563 |
Marketable securities | 0 | 13,371 |
Prepaid expenses and other current assets | 3,081 | 7,558 |
Total current assets | 56,558 | 98,492 |
Property and equipment, net | 14,469 | 6,053 |
Other assets | 3,660 | 4,087 |
Total assets | 74,687 | 108,632 |
Current liabilities | ||
Accounts payable | 2,921 | 8,062 |
Accrued expenses and other current liabilities | 6,399 | 9,900 |
Operating lease obligations | 540 | 498 |
Current portion of long term debt | 1,276 | 0 |
Total current liabilities | 11,136 | 18,460 |
Non-current liabilities | ||
Operating lease obligations, less current portion | 3,164 | 3,587 |
Long term debt, net | 1,495 | 2,289 |
Other non-current liabilities | 497 | 244 |
Total non-current liabilities | 5,156 | 6,120 |
Total liabilities | 16,292 | 24,580 |
Commitments and contingencies | ||
Stockholders' equity | ||
Common stock; $0.01 par value; 295,000,000 shares authorized, 256,621,487 and 221,721,182 shares issued, and 256,499,987 and 221,599,682 shares outstanding at September 30, 2023 and December 31, 2022, respectively | 2,566 | 2,217 |
Treasury stock, at cost, 121,500 shares at September 30, 2023 and December 31, 2022 | (48) | (48) |
Additional paid-in capital | 322,452 | 294,874 |
Accumulated other comprehensive income | 27 | 26 |
Accumulated deficit | (266,603) | (213,018) |
Total stockholders' equity | 58,395 | 84,052 |
Total liabilities and stockholders' equity | 74,687 | 108,632 |
Series A Preferred Stock | ||
Stockholders' equity | ||
Preferred stock issued | 0 | 0 |
Series B Preferred Stock | ||
Stockholders' equity | ||
Preferred stock issued | $ 1 | $ 1 |